IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice

Cytokine

Volumn 34, Issue 1-2, 2006, Pages 85-95

  Rajagopalan, Govindarajan ^a   Kudva, Yogish C ^b   Sen, Moon M ^a   Marietta, Eric V ^a   Murali, Narayana ^b   Nath, Karl ^b   Moore, Jodi ^c   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c NONE   (United States)

Author keywords

Autoimmunity; Colitis and rectal prolapse; Cytokine; Diabetes; IL 10; Knockout mice; Non obese diabetic mice; Rodents; Type 1 diabetes

Indexed keywords

CYCLOPHOSPHAMIDE; FREUND ADJUVANT; INTERLEUKIN 10; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; COLITIS; CONTROLLED STUDY; CPG ISLAND; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNE SYSTEM; INCIDENCE; INSULITIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECTUM PROLAPSE; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNITY; CPG ISLANDS; FEMALE; FREUND'S ADJUVANT; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PHENOTYPE; TOLL-LIKE RECEPTORS;

EID: 33744517332     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.04.006     Document Type: Article

References (61)

1. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
2. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157 (1996) 798-805
3. Murray P.J., and Young R.A. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67 (1999) 3087-3095
4. Sewnath M.E., Olszyna D.P., Birjmohun R., ten Kate F.J., Gouma D.J., and van Der Poll T. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166 (2001) 6323-6331
5. Li C., Sanni L.A., Omer F., Riley E., and Langhorne J. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Infect Immun 71 (2003) 4850-4856
6. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., and Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161 (1998) 3299-3306
7. Anderson A.C., Reddy J., Nazareno R., Sobel R.A., Nicholson L.B., and Kuchroo V.K. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol 173 (2004) 828-834
8. Finnegan A., Kaplan C.D., Cao Y., Eibel H., Glant T.T., and Zhang J. Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res Ther 5 (2003) R18-R24
9. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
10. Mahler M., and Leiter E.H. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis 8 (2002) 347-355
11. Davidson N.J., Leach M.W., Fort M.M., Thompson-Snipes L., Kuhn R., Muller W., et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184 (1996) 241-251
12. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66 (1998) 5224-5231
13. Madsen K.L., Doyle J.S., Tavernini M.M., Jewell L.D., Rennie R.P., and Fedorak R.N. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118 (2000) 1094-1105
14. Bach J.F., and Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 19 (2001) 131-161
15. Serreze D.V., Chapman H.D., Post C.M., Johnson E.A., Suarez-Pinzon W.L., and Rabinovitch A. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166 (2001) 1352-1359
16. Baxter A.G., Koulmanda M., and Mandel T.E. High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. Autoimmunity 9 (1991) 61-67
17. Atkinson M.A., and Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat Med 5 (1999) 601-604
18. Leiter E. The NOD mouse: a model for insulin-dependent diabetes mellitus (2001), John Wiley & Sons Inc., New York
19. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110 (2004) 252-266
20. Rajagopalan G., Kudva Y.C., Chen L., Wen L., and David C.S. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol 15 (2003) 1035-1044
21. Balasa B., Van Gunst K., Jung N., Katz J.D., and Sarvetnick N. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell Immunol 202 (2000) 97-102
22. Mahler M., Bristol I.J., Leiter E.H., Workman A.E., Birkenmeier E.H., Elson C.O., et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274 (1998) G544-G551
23. Mahler M., Bristol I.J., Sundberg J.P., Churchill G.A., Birkenmeier E.H., Elson C.O., et al. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 55 (1999) 147-156
24. Elson C.O., Konrad A., Cong Y., and Weaver C.T. Gene disruption and immunity in experimental colitis. Inflamm Bowel Dis 10 Suppl. 1 (2004) S25-S28
25. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
26. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
27. Davila E., Velez M.G., Heppelmann C.J., and Celis E. Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment. Blood 100 (2002) 2537-2545
28. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96 (1995) 2339-2347
29. Dai W.J., Kohler G., and Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 158 (1997) 2259-2267
30. Bettelli E., Nicholson L.B., and Kuchroo V.K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J Autoimmun 20 (2003) 265-267
31. Bettelli E., Prabhu Das M., Howard E.D., Weiner H.L., Sobel R.A., and Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161 (1998) 3299-3306
32. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F., Linde H.-.J., et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69 (2001) 2277-2285
33. Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108 (2001) 1097-1104
34. von Herrath M.G., Fujinami R.S., and Whitton J.L. Microorganisms and autoimmunity: making the barren field fertile?. Nat Rev Microbiol 1 (2003) 151-157
35. + T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA 100 (2003) 15806-15811
36. Wong F.S., and Janeway Jr. C.A. The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun 13 (1999) 290-295
37. Lee K.U., Amano K., and Yoon J.W. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37 (1988) 989-991
38. Jun H.S., Yoon C.S., Zbytnuik L., van Rooijen N., and Yoon J.W. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189 (1999) 347-358
39. + T-cells in T-cell receptor transgenic NOD mice. Diabetes 48 (1999) 34-42
40. Lang R., Patel D., Morris J.J., Rutschman R.L., and Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169 (2002) 2253-2263
41. Takakura R., Kiyohara T., Murayama Y., Miyazaki Y., Miyoshi Y., Shinomura Y., et al. Enhanced macrophage responsiveness to lipopolysaccharide and CD40 stimulation in a murine model of inflammatory bowel disease: IL-10-deficient mice. Inflamm Res 51 (2002) 409-415
42. Nikolic T., Bunk M., Drexhage H.A., and Leenen P.J. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. J Immunol 173 (2004) 4342-4351
43. Serreze D.V., Gaedeke J.W., and Leiter E.H. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 90 (1993) 9625-9629
44. Kullberg M.C., Rothfuchs A.G., Jankovic D., Caspar P., Wynn T.A., Gorelick P.L., et al. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun 69 (2001) 4232-4241
45. Kullberg M.C., Ward J.M., Gorelick P.L., Caspar P., Hieny S., Cheever A., et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 66 (1998) 5157-5166
46. Dieleman L.A., Arends A., Tonkonogy S.L., Goerres M.S., Craft D.W., Grenther W., et al. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun 68 (2000) 5107-5113
47. Zhang L., Danon S.J., Grehan M., Chan V., Lee A., and Mitchell H. Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice. Helicobacter 10 (2005) 223-230
48. Latifi S.Q., O'Riordan M.A., and Levine A.D. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70 (2002) 4441-4446
49. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265-277
50. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Tennent B., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154 (1995) 180-191
51. + T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol 107 (2003) 103-115
52. Lesage S., Hartley S.B., Akkaraju S., Wilson J., Townsend M., and Goodnow C.C. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 196 (2002) 1175-1188
53. Kishimoto H., and Sprent J. A defect in central tolerance in NOD mice. Nat Immunol 2 (2001) 1025-1031
54. Yang Y., Bao M., and Yoon J.W. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Diabetes 50 (2001) 2691-2699
55. Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shepherd D., Naidenko O.V., et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol 13 (2001) 887-896
56. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109 (2002) 131-140
57. Koonce C.H., and Bikoff E.K. Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice. J Immunol 173 (2004) 3271-3280
58. Silveira P.A., Dombrowsky J., Johnson E., Chapman H.D., Nemazee D., and Serreze D.V. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol 172 (2004) 5086-5094
59. Serreze D.V., Gaskins H.R., and Leiter E.H. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150 (1993) 2534-2543
60. Li F., Guo J., Fu Y., Yan G., and Faustman D. Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. Proc Natl Acad Sci USA 91 (1994) 11128-11132
61. Grohmann U., Fallarino F., Bianchi R., Orabona C., Vacca C., Fioretti M.C., et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198 (2003) 153-160